The Current Ratio as of November 2024 (TTM) for Evogene Ltd. (EVGN) is 4.37

According to Evogene Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.37. This represents a change of -15.30% compared to the average of 5.16 of the last 4 quarters.

Evogene Ltd. (EVGN) Historical Current Ratio (quarterly & annually)

How has EVGN Current Ratio performed in the past?

The mean historical Current Ratio of Evogene Ltd. over the last ten years is 11.03. The current 4.37 Current Ratio has changed 3.87% with respect to the historical average. Over the past ten years (40 quarters), EVGN's Current Ratio was at its highest in in the September 2015 quarter at 22.85. The Current Ratio was at its lowest in in the June 2024 quarter at 4.37.

Evogene Ltd. (EVGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Evogene Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evogene Ltd. (EVGN) Average Current Ratio

How has EVGN Current Ratio performed in the past?

The current Current Ratio of Evogene Ltd. (EVGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evogene Ltd. (EVGN) Current Ratio vs. Peers

How is EVGN’s Current Ratio compared to its peers?

Evogene Ltd.’s Current Ratio is less than Arcus Biosciences, Inc. (5.24), less than Fate Therapeutics, Inc. (8.29), less than Surface Oncology, Inc. (7.94), less than Pluri Inc. (5.90), less than Lexaria Bioscience Corp. (58.27), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than ZyVersa Therapeutics, Inc. (0.03), greater than Biodexa Pharmaceuticals Plc (2.16), greater than Oncorus, Inc. (1.74), greater than Can-Fite BioPharma Ltd. (2.93), greater than ImmuCell Corporation (3.11), greater than Compugen Ltd. (4.14), less than CollPlant Biotechnologies Ltd. (6.27), less than Protalix BioTherapeutics, Inc. (0), greater than Corvus Pharmaceuticals, Inc. (1.98), greater than Aldeyra Therapeutics, Inc. (0.92), less than Gamida Cell Ltd. (6.80), greater than Checkpoint Therapeutics, Inc. (0.35), greater than null (0.29),

Build a custom stock screener for Evogene Ltd. (EVGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evogene Ltd. (EVGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.